Table 4. Comparison of outcomes between case series, review of literature of robotic pelvic exenteration and open pelvic exenteration.
| Variable | Case series | Literature review of robotic exenteration | Platt et al. [9] | Quyn et al. [16] | PelvEx Collaborative |
|---|---|---|---|---|---|
| Sample size | 7 | 7 | 1,016 | 104 | 1,184 |
| Age (y) | 60 (46–79) | 57 (41–78) | 59 (50–65) | 62 (27–86) | 63 (IQR, 56–69) |
| Sex (male/female) | 7/0 | 7/0 | 640/376 | 54/50 | 752/432 |
| Body mass index (kg/m2) | 25.1 (18.1–31.6) | 22.9 (18–27) | - | - | 25 (22–28) |
| ASA score (1/2/3/4) | 3/3/1/0 | 2/0/0/0 | - | 17/54/17/0 | - |
| Charlson Comorbidity index | 3 (3–6) | 2 (2–3) | - | - | - |
| Operative time (min) | 485±157 | 522±133 | 444 (266–726) | 438 (132–930) | 509±201 |
| Blood loss (mL) | 375 (0–1,000) | 600 (300–800) | 2,114 (540–7,550) | 1,500 (100–13,000) | - |
| Length of stay | 9 (6–34) | 8 (7–28) | 18 (9–49) | 19 (7–97) | 15 (IQR, 10–46) |
| Clavien-Dindo Classification Grade (I–II/III–IV) | 7/0 | 1/1 | 380/280 | -/8 | -/380 |
| Return to theatre (%) | 0.0 | 0.0 | 14.6 | 5.0 | 7.2 |
| 30 day mortality (%) | 0.0 | 0.0 | 0.0 (0.0–8.7) | 1.0 | 1.8 |
| R0 resection (%) | 85.7 | 85 | 74 | 86 | 55.4 |
| Adjuvant therapy (yes/no) | 4/3 | 3/7 | - | - | - |
| Neoadjuvant therapy (yes/no) | 5/2 | 4/7 | - | - | 614/515 |
| 5 year survival (%) | 85.7 | 100.0 | 32.0 | * | 22.5 |
Values are presented as number only, median (range), mean±standard deviation, percent only, or median only.
ASA, American Society of Anesthesiologists; IQR, interquartile range; -, not available.
*Denotes missing data.